ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Formaldehyde → (1r)-9-[(3s,4s)-1,3-Dimethylpiperidin-4-Yl]-8-(2-Fluorophenyl)-1-Methyl-3,5-Dihydro[1,2,4]triazino[3,4-C][1,4]benzoxazin-2(1h)-One

HRID 519175
印刷

反応式

HRID 519175 の反応式
Cl.[F:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[C:9]1[CH:22]=[C:21]2[C:12]([N:13]3[C:18]([CH2:19][O:20]2)=[N:17][NH:16][C:15](=[O:23])[C@H:14]3[CH3:24])=[CH:11][C:10]=1[C@H:25]1[CH2:30][CH2:29][NH:28][CH2:27][C@H:26]1[CH3:31].C=O.[B-][C:35]#N.[Na+]>CO.CC(O)=O>[CH3:35][N:28]1[CH2:29][CH2:30][C@H:25]([C:10]2[CH:11]=[C:12]3[C:21](=[CH:22][C:9]=2[C:4]2[CH:5]=[CH:6][CH:7]=[CH:8][C:3]=2[F:2])[O:20][CH2:19][C:18]2[N:13]3[C@H:14]([CH3:24])[C:15](=[O:23])[NH:16][N:17]=2)[C@H:26]([CH3:31])[CH2:27]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 712FormaldehydeHCID 20587905Sodium cyanoborohydride [MI]HCID 86727582(R)-7-(2-fluoro-phenyl)-4-methyl-6-((3S,4S)-3-methyl-piperidin-4-yl)-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one hydrochloride

生成物 1

HCID 86727584(1r)-9-[(3s,4s)-1,3-Dimethylpiperidin-4-Yl]-8-(2-Fluorophenyl)-1-Methyl-3,5-Dihydro[1,2,4]triazino[3,4-C][1,4]benzoxazin-2(1h)-One収率 70.2%

試薬・触媒・溶媒 2

HCID 176Acetic Acid溶媒
HCID 887Methanol溶媒

実験手順

A mixture of (R)-7-(2-fluoro-phenyl)-4-methyl-6-((3S,4S)-3-methyl-piperidin-4-yl)-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one hydrochloride acid (3.0 g, 6.74 mmol) and paraformaldehyde (0.506 g, 16.86 mmol) in MeOH (100 mL) and AcOH (10 mL) was stirred at ambient temperature for 2 h. Then, sodium cyanotrihydroborate (0.847 g, 13.49 mmol) was added and the reaction mixture was stirred at ambient temperature for 0.5 h. The reaction mixture was concentrated in vacuo and the residue was purified by column chromatography on basified silica gel (eluting with 10% MeOH in EA) to give (R)-6-((3S,4S)-1,3-dimethyl-piperidin-4-yl)-7-(2-fluoro-phenyl)-4-methyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one (2.0 g, 65%) as a white solid. The white solid was stirred in HCl/EtOAc (4 M, 15 mL) for 30 min and the reaction mixture was concentrated in vacuo to give (R)-6-((3S,4S)-1,3-dimethyl-piperidin-4-yl)-7-(2-fluoro-phenyl)-4-methyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one hydrochloride acid (1.65 g, 53%) as a white solid. 1H NMR (400 MHz, methanol-d4) δ 7.49-7.40 (m, 1H), 7.33-7.17 (m, 3H), 6.91 (s, 1H), 6.85 (s, 1H), 4.99-4.93 (m, 1H), 4.70-4.65 (m, 2H), 3.60-3.50 (m, 1H), 3.25-3.00 (m, 3H), 2.90-2.85 (m, 1H), 2.80 (s, 3H), 2.55-2.45 (m, 1H), 2.01-1.84 (m, 2H), 1.49 (d, J=6.4 Hz, 3H), 1.00-0.90 (m, 3H). LC/MS (Table 1, Method 4) Rt=1.654 min.; MS m/z: 423 [M+H]+. SFC (Table 1, Method 48), Rt=3.206 min.

後処理

  1. stirringthe reaction mixture was stirred at ambient temperature for 0.5 h
  2. concentrationThe reaction mixture was concentrated in vacuo
  3. customthe residue was purified by column chromatography on basified silica gel (eluting with 10% MeOH in EA)

出典と根拠

ORDレコード
ord-419ea072d1a7418d91f504162d979b0a
出典データセット
uspto-grants-2015_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09115151B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート